Metatag Title
World Top Healthcare Companies in 2024
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2024, World Top Healthcare Companies by Market Cap in 2024.
World Top 100 Healthcare Companies List by Market Cap in January 2024, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as pf Jan-05-2024.
Iveric Bio is an Innovative Biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with significant unmet medical needs. Iveric Bio 163 employees as on 2022. The headquarters is in USA.
Astellas Pharma Inc. (TSE: 4503) has completed the acquisition of IVERIC bio, Inc. (NASDAQ: ISEE) on July 11, 2023 and the acquisition price of the same was 5.9 billion USD.
McKesson Europe AG is a healthcare company. It is active in 13 countries and works with their partners to provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost effectively. The headquarters is in USA.
As on 2019, it had 1,900 retail pharmacies in five countries and 6,900 partner and brand partner pharmacies.
Diasorin is biotechnology sector company with headquarters is in Italy. Diasorin operates in the laboratory diagnostics market, providing both private and hospital microbiology laboratories with innovative solutions. Headquarters is in Italy.
As on 2019, Diasorin has 1,939 employees.
LHC Group is a Healthcare Services company. It provides high quality care to patients through home health, hospitals, home and community based services and facility based care. The company healthcare services with 32,000 employees operating in 35 states and the district of Columbia reaching 60 percent of the U.S. population aged 65 and older. The headquarters is in USA.
UnitedHealth acquired LHC Group for 5.4 billion USD and closed the deal in Feb-2023.
Bio-pharmaceutical company with headquarters is in Massachusetts, USA.
Abcam is a Biological Reagents company. It is essential in a wide range of fields and applications including drug discovery, diagnostics and basic research and present across eleven sites globally. The headquarters is in UK.
Abcam is the leading Supplier of Protein Research Tools to Life Scientists company. The company annual revenue is 316.8 million USD and 1,492 employees as on 2019.
Danaher has acquired Abcam for 5.7 billion USD in 2023.
Abcam annual revenue was 361 million GBP and annual net loss was -8 million GBP generated for period year ending Dec-2022.
Abcam annual revenue was 315 million GBP and annual net income was 4 million GBP generated for period year ending Dec-2021.
As on 2022, Abcam had 1760 employees.